Edge Therapeutics, Inc. (21)

Browse by Contract Category

Contracts

Executive Employment Agreement by and between PDS Biotechnology Corporation and Matthew Hill, dated as of October 4, 2021 (Filed With SEC on October 6, 2021)
Underwriting Agreement, dated June 15, 2021, by and among PDS Biotechnology Corporation and Cantor Fitzgerald & Co (Filed With SEC on June 17, 2021)
PDS Biotechnology Corporation 2019 Inducement Plan, as amended (Filed With SEC on December 9, 2020)
Sublease Agreement, effective as of March 5, 2020, by and between PDS Biotechnology Corporation and COWI North America, Inc (Filed With SEC on March 27, 2020)
Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement, dated as of October 28, 2019, by and between PDS Biotechnology Corporation and MSD International GmbH (Filed With SEC on November 7, 2019)
Amendment No. 1 to Agreement and Plan of Merger and Reorganization, dated as of January 24, 2019, by and among Edge Therapeutics, Inc., Echos Merger Sub, Inc. and PDS... (Filed With SEC on January 30, 2019)
Amendment to Employment Agreement by and between PDS Biotechnology Corporation and Gregory Conn, Ph.D., effective as of June 17, 2021 (Filed With SEC on June 21, 2021)
Form of Employee Stock Option Agreement under the Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on December 9, 2020)
Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on December 9, 2020)
Executive Employment Agreement by and between the Company and Seth L. Van Voorhees, Ph.D (Filed With SEC on December 9, 2020)
Underwriting Agreement dated August 11, 2020 (Filed With SEC on August 13, 2020)
Consulting Agreement (Michael King) (Filed With SEC on June 24, 2020)
Description of Securities (Filed With SEC on March 27, 2020)
Form of Underwriting Agreement (Filed With SEC on January 17, 2020)
Offer Letter, dated February 1, 2019, by and between PDS Biotechnology Corporation and Lauren V. Wood, M.D (Filed With SEC on August 1, 2019)
Employment Agreement, effective June 1, 2019, by and between PDS Biotechnology Corporation and Gregory Conn (Filed With SEC on August 1, 2019)
Common Stock Purchase Agreement, dated July 29, 2019 between PDS Biotechnology Corporation and Aspire Capital Fund, LLC (Filed With SEC on July 30, 2019)
Registration Rights Agreement, dated July 29, 2019, between PDS Biotechnology Corporation and Aspire Capital Fund, LLC (Filed With SEC on July 30, 2019)
Form of Stock Option Grant Notice and Stock Option Agreement under the 2019 Inducement Plan (Filed With SEC on June 20, 2019)
PDS Biotechnology Corporation 2019 Inducement Plan (Filed With SEC on June 20, 2019)
Letter Agreement, dated as of February 3, 2019, by and among Edge Therapeutics, Inc., PDS Biotechnology Corporation and Brian A. Leuthner (Filed With SEC on February 4, 2019)